Indian Stocks signal
TORNTPHARM

TORNTPHARM

Torrent Pharmaceuticals Limited · Healthcare

Indian StocksDrug Manufacturers - Specialty & GenericNSIINR-2.3% from ATH
Current Price

$4,466.70

Drawdown from ATH

-2.3%

Last Updated

Jun 17, 2026

Dipsern Grade90d

D

Weak

Graded against TORNTPHARM's own history at this drawdown — not the market's.

What it means: TORNTPHARM's own history does not strongly favor buying at this level yet.

What to do: Consider watching and waiting for a deeper dip or a higher grade.

Median 90-Day Return
Historical Win Rate
Last 30 days+2.49%
May 6Jun 16
About TORNTPHARM

Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as

The reading

How Dipsern reads TORNTPHARM right now.

Three plain-English paragraphs — current state, historical base rate, and interpretation — so you walk away with context, not a dashboard.

Snapshot

How is TORNTPHARM doing right now?

In plain terms: TORNTPHARM is 2.3% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.

Torrent Pharmaceuticals Ltd. (TORNTPHARM) sits 2.3% off its peak and is currently in a shallow pullback, last printing at $4,466.7. Shallow pullbacks like this are routine — historically Indian Stocks assets revisit a 5-10% dip several times a year, and most resolve back to highs within weeks.

Historical base rate

What history says at this drawdown

History at this drawdown level is well-populated for TORNTPHARM — 1961 confirmed observations in the 5%-to-0% band. The Dipsern engine uses these to compute a rolling median rather than a mean, because medians are robust to the kind of fat tails you find in indian stocks return distributions. The win rate (% of episodes that closed positive after 90 days) is shown in the segments table below.

Interpretation

What this means for TORNTPHARM

Drawdown-based signals work across asset classes but the magnitude of meaningful moves varies. Dipsern computes the segmentation per-asset so the bands are calibrated to TORNTPHARM's own volatility history. Shallow pullbacks are where dip-buying frameworks start to pay off, but only marginally. The median forward return in shallow bands is usually positive but not dramatic.

Comparable signals

Other Indian Stocks at similar drawdown levels

Five tickers closest to TORNTPHARM's distance from all-time high. Same category, one tap away.

Axis Bank Ltd.

-2.7% from ATH

JSW Steel Ltd.

-2.9% from ATH

Apollo Hospitals Enterprise Ltd.

-1.6% from ATH

Divi's Laboratories Ltd.

-3.4% from ATH

Grasim Industries Ltd.

-1.0% from ATH

Historical depth

Sample sizes by drawdown band

Dipsern segments the full drawdown range into 20 equal-width bands. The table shows the number of confirmed historical observations in each band for TORNTPHARM. Median forward returns, win rates, and prediction errors are available in the full analysis.

Drawdown BandObservationsMedian ReturnWin Rate
-60% to -55%8
-55% to -50%81
-50% to -45%69
-45% to -40%103
-40% to -35%65
-35% to -30%209
-30% to -25%313
-25% to -20%508
-20% to -15%587
-15% to -10%745
-10% to -5%1242
-5% to 0%Current1961
Methodology

Every grade is reproducible.

We segment 40+ years of TORNTPHARM's price history into 20 equal-width drawdown bands and compute forward median returns, win rates, and prediction error per band. No look-ahead bias. Pure NumPy. Open math, gated numbers.

Years of history

40+

Drawdown bands

20

Look-ahead bias

None

Data sources

4

Unlock TORNTPHARM's full analysis

See the Dipsern grade, median returns, win rates, prediction accuracy, 8 interactive charts, historical price paths, and a plain-English verdict for TORNTPHARM.

Dipsern is research and a second opinion — not a broker. You'd buy TORNTPHARM at your own broker.

Analyze TORNTPHARM Free

No credit card required · 5 free analyses per month

Signal computed Jun 17, 2026 using default parameters (90-day return period, 20 segments, 0.95 decay). Data sourced from Yahoo Finance, Binance, CoinGecko, and Steam Market.